Hogan Lovells Represents GE in Acquisition of Strategic Assets from Thermo Fisher Scientific
09 January 2014
WASHINGTON, D.C. 9 January 2014 – Hogan Lovells represented GE Healthcare in connection with its agreement to acquire Thermo Fisher Scientific’s HyClone™ cell culture media and sera, gene modulation and magnetic beads businesses for approximately US$1.06 billion. The businesses will become part of GE Healthcare's Life Sciences division. The deal was announced on 6 January, 2014.
Hogan Lovells Washington, D.C. partners Joseph Gilligan and Paul Manca led the multidisciplinary team advising GE Healthcare with assistance from Warren Gorrell (Co-CEO, Washington, D.C.) and other partners and counsel from the corporate, regulatory, intellectual property, tax, environmental, real estate, employment and employee benefits groups, including: Christine Burke, Celine Crowson, Dan Davidson, Beth Peters, Randy Prebula, Audrey Reed, Scott Reisch, Anthony Ryan, Amit Saluja, Martha Steinman, T. Weymouth and Michael Williams.